Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Bronchus-associated lymphoid tissue (BALT) lymphoma is a rare subtype of extra-nodal marginal zone B-cell lymphomas, accounting for less than 5% of cases. It is typically indolent and often discovered incidentally through imaging studies performed for unrelated reasons. We present the case of a 72-year-old male with a known history of thoracic aortic dilatation, who was found to have a spiculated right upper lobe (RUL) pulmonary nodule on surveillance imaging. He remained asymptomatic, with no constitutional or respiratory symptoms. Positron emission tomography imaging demonstrated mildly increased uptake (standardized uptake value 2.4) of the RUL nodule, and no mediastinal or hilar lymphadenopathy. Bronchoscopic biopsy with histopathology and immunohistochemistry revealed a low-grade B-cell non-Hodgkin's lymphoma, with CD20 and BCL2 positivity. Flow cytometry confirmed monoclonal B-cell proliferation, and fluorescence in situ hybridization analysis identified the BIRC3-MALT1 translocation, consistent with BALT lymphoma. The patient was staged as IE, and a decision was made for conservative management with active surveillance, given the localized and asymptomatic nature of his disease. While treatment options may include surgery, radiotherapy, immunotherapy, or chemotherapy, there is no consensus on the optimal approach due to the rarity and heterogeneous presentation of this lymphoma. In many early-stage cases without symptoms, a "watch and wait" strategy is reasonable. This case underscores the importance of including BALT lymphoma in the differential diagnosis of incidental pulmonary nodules and highlights the need for greater awareness and research to establish standardized treatment protocols, with each case adding valuable insight to guide future management strategies.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12368405PMC
http://dx.doi.org/10.1177/23247096251366125DOI Listing

Publication Analysis

Top Keywords

balt lymphoma
12
bronchus-associated lymphoid
8
lymphoid tissue
8
lymphoma
6
maltoma 'b'-not
4
'b'-not benign
4
benign bronchus-associated
4
bronchus-associated rare
4
case
4
rare case
4

Similar Publications

Bronchus-associated lymphoid tissue (BALT) lymphoma is a rare subtype of extra-nodal marginal zone B-cell lymphomas, accounting for less than 5% of cases. It is typically indolent and often discovered incidentally through imaging studies performed for unrelated reasons. We present the case of a 72-year-old male with a known history of thoracic aortic dilatation, who was found to have a spiculated right upper lobe (RUL) pulmonary nodule on surveillance imaging.

View Article and Find Full Text PDF

In this case report we describe a patient who was diagnosed with extranodal marginal zone lymphoma (EMZL) at two different body sites, namely at the mucosa of the stomach and the lung. Since the patient presented with a main complaint of dyspnoea, this was a rather unexpected medical finding. To our knowledge, this is even the first case of multifocal EMZL in which the coexistent involvement of the stomach and lung is extensively documented.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the microbiome in bronchus-associated lymphoid tissue (BALT) lymphoma, a rare type of MALT lymphoma in the lungs, using advanced sequencing methods.
  • DNA was extracted from tumor tissues of BALT lymphoma patients to analyze bacterial profiles, revealing specific bacterial families that were more abundant in these tumors compared to non-cancerous lung tissues.
  • Findings indicate that BALT lymphomas have a unique microbial composition and a distinct tumor microenvironment, providing new insights into the role of the microbiome in this type of lymphoma.
View Article and Find Full Text PDF
Article Synopsis
  • Bronchus-associated lymphoid tissue (BALT) lymphoma, or BALToma, is a rare type of cancer that often has a slow progression, leading many patients to adopt a watch-and-wait strategy instead of immediate treatment.
  • A study of 67 patients from three hospitals in Korea found that patients who were just monitored or received minimal treatment had better long-term survival outcomes than those who underwent systemic chemotherapy: 10-year overall survival was 100% for the observation group compared to 71.7% for the chemotherapy group.
  • Factors like having both lungs involved or extrapulmonary organ involvement were associated with worse progression-free survival, indicating that such patients may need closer monitoring and potentially more aggressive treatment options.
View Article and Find Full Text PDF

The disease failure patterns and optimal treatment of bronchus-associated lymphoid tissue (BALT) lymphoma are unknown. This retrospective study involved 71 patients with primary BALT lymphoma who had received radiotherapy (RT), surgery, immunochemotherapy (IC), or observation. The median follow-up time was 66 months.

View Article and Find Full Text PDF